Hon Dr AYESHA VERRALL: Last month, I announced a new testing strategy to support the transition to the new framework and to help minimise the spread of COVID-19. A key part of that plan was expanding our PCR testing capacity. By the end of the year, we are on track to have a standing capacity for 40,000 PCR tests per day, and that will build to 60,000 in the first quarter of next year. Nasopharyngeal PCR tests will continue to be used as the primary diagnostic test, but this will be supplemented by saliva-based PCR testing, rapid antigen testing, and rapid PCR tests.